Translation is not required to generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells

Journal of Virology

Volumn 74, Issue 24, 2000, Pages 11531-11537

  Butsch, M ^a   Boris Lawrie, K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RIBONUCLEASE; RNA;

ARTICLE; CELL FREE SYSTEM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HYPOTHESIS; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SPLICING; RNA TRANSLATION; T LYMPHOCYTE; VIRION;

HIV INFECTIONS; HIV-1; HUMANS; PROTEIN BIOSYNTHESIS; RNA, VIRAL; T-LYMPHOCYTES; VIRION; VIRUS REPLICATION;

EID: 0034467887     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.24.11531-11537.2000     Document Type: Article

References (24)

1. Expression of cellular genes in CD4 positive lymphoid cells infected by the human immunodeficiency virus, HIV-1: Evidence for a host protein synthesis shut-off induced by cellular mRNA degradation
2. The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production
3. Assessment of cell viability
4. Inhibition of protein synthesis in reticulocytes by antibiotics. II. The site of action of cycloheximide, streptovitacin A and pactamycin
5. Initiation of the polypeptide chain by reticulocyte cell-free systems. Survey of different inhibitors of translation
6. Variable inhibition of cell-free translation by HIV-1 transcript leader sequences
7. Mechanisms of action of antitumor antibiotic inhibitors of protein synthesis
8. Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation
9. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1
10. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D
11. Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: Evidence for persistence of viral messenger RNA
12. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures
13. Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation
14. Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2
15. Metabolism of viral RNA in murine leukemia virus-infected cells; evidence for differential stability of viral message and virion precursor RNA
16. The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm
17. The human immunodeficiency virus type 1 5′ packaging signal structure affects translation but does not function as an internal ribosome entry site structure
18. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
19. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes
20. Dependence of Moloney murine leukemia virus production on cell growth
21. The 5′ RNA terminus of spleen necrosis virus stimulates translation of nonviral mRNA
22. gag
23. Stabilities of avian sarcoma virus RNAs: Comparison of subgenomic and genomic species with cellular mRNAs
24. Inhibitors of protein biosynthesis